Global Respiratory Distress Syndrome Market Growth (Status and Outlook) 2025-2031

January 2025 | 84 pages | ID: GDE2F23300DEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Respiratory Distress Syndrome market size is predicted to grow from US$ 411 million in 2025 to US$ 573 million in 2031; it is expected to grow at a CAGR of 5.7% from 2025 to 2031.

Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.

North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.

LPI (LP Information)' newest research report, the “Respiratory Distress Syndrome Industry Forecast” looks at past sales and reviews total world Respiratory Distress Syndrome sales in 2024, providing a comprehensive analysis by region and market sector of projected Respiratory Distress Syndrome sales for 2025 through 2031. With Respiratory Distress Syndrome sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Respiratory Distress Syndrome industry.

This Insight Report provides a comprehensive analysis of the global Respiratory Distress Syndrome landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Respiratory Distress Syndrome portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Respiratory Distress Syndrome market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Respiratory Distress Syndrome and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Respiratory Distress Syndrome.

This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Distress Syndrome market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Poractant Alfa
• Beractant
• Calfactant
• Others

Segmentation by Application:

• Very Preterm Infants
• Moderate to Late Preterm Infants
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Chiesi Farmaceutici
• CR-Double Crane
• ONY Biotech
• AbbVie
• Yuhan Corporation
• JW Pharmaceuticals
• Noargen

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Respiratory Distress Syndrome Market Size (2020-2031)
  2.1.2 Respiratory Distress Syndrome Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Respiratory Distress Syndrome by Country/Region (2020, 2024 & 2031)
2.2 Respiratory Distress Syndrome Segment by Type
  2.2.1 Poractant Alfa
  2.2.2 Beractant
  2.2.3 Calfactant
  2.2.4 Others
2.3 Respiratory Distress Syndrome Market Size by Type
  2.3.1 Respiratory Distress Syndrome Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Respiratory Distress Syndrome Market Size Market Share by Type (2020-2025)
2.4 Respiratory Distress Syndrome Segment by Application
  2.4.1 Very Preterm Infants
  2.4.2 Moderate to Late Preterm Infants
  2.4.3 Others
2.5 Respiratory Distress Syndrome Market Size by Application
  2.5.1 Respiratory Distress Syndrome Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Respiratory Distress Syndrome Market Size Market Share by Application (2020-2025)

3 RESPIRATORY DISTRESS SYNDROME MARKET SIZE BY PLAYER

3.1 Respiratory Distress Syndrome Market Size Market Share by Player
  3.1.1 Global Respiratory Distress Syndrome Revenue by Player (2020-2025)
  3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by Player (2020-2025)
3.2 Global Respiratory Distress Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RESPIRATORY DISTRESS SYNDROME BY REGION

4.1 Respiratory Distress Syndrome Market Size by Region (2020-2025)
4.2 Global Respiratory Distress Syndrome Annual Revenue by Country/Region (2020-2025)
4.3 Americas Respiratory Distress Syndrome Market Size Growth (2020-2025)
4.4 APAC Respiratory Distress Syndrome Market Size Growth (2020-2025)
4.5 Europe Respiratory Distress Syndrome Market Size Growth (2020-2025)
4.6 Middle East & Africa Respiratory Distress Syndrome Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Respiratory Distress Syndrome Market Size by Country (2020-2025)
5.2 Americas Respiratory Distress Syndrome Market Size by Type (2020-2025)
5.3 Americas Respiratory Distress Syndrome Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Respiratory Distress Syndrome Market Size by Region (2020-2025)
6.2 APAC Respiratory Distress Syndrome Market Size by Type (2020-2025)
6.3 APAC Respiratory Distress Syndrome Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Respiratory Distress Syndrome Market Size by Country (2020-2025)
7.2 Europe Respiratory Distress Syndrome Market Size by Type (2020-2025)
7.3 Europe Respiratory Distress Syndrome Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Respiratory Distress Syndrome by Region (2020-2025)
8.2 Middle East & Africa Respiratory Distress Syndrome Market Size by Type (2020-2025)
8.3 Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RESPIRATORY DISTRESS SYNDROME MARKET FORECAST

10.1 Global Respiratory Distress Syndrome Forecast by Region (2026-2031)
  10.1.1 Global Respiratory Distress Syndrome Forecast by Region (2026-2031)
  10.1.2 Americas Respiratory Distress Syndrome Forecast
  10.1.3 APAC Respiratory Distress Syndrome Forecast
  10.1.4 Europe Respiratory Distress Syndrome Forecast
  10.1.5 Middle East & Africa Respiratory Distress Syndrome Forecast
10.2 Americas Respiratory Distress Syndrome Forecast by Country (2026-2031)
  10.2.1 United States Market Respiratory Distress Syndrome Forecast
  10.2.2 Canada Market Respiratory Distress Syndrome Forecast
  10.2.3 Mexico Market Respiratory Distress Syndrome Forecast
  10.2.4 Brazil Market Respiratory Distress Syndrome Forecast
10.3 APAC Respiratory Distress Syndrome Forecast by Region (2026-2031)
  10.3.1 China Respiratory Distress Syndrome Market Forecast
  10.3.2 Japan Market Respiratory Distress Syndrome Forecast
  10.3.3 Korea Market Respiratory Distress Syndrome Forecast
  10.3.4 Southeast Asia Market Respiratory Distress Syndrome Forecast
  10.3.5 India Market Respiratory Distress Syndrome Forecast
  10.3.6 Australia Market Respiratory Distress Syndrome Forecast
10.4 Europe Respiratory Distress Syndrome Forecast by Country (2026-2031)
  10.4.1 Germany Market Respiratory Distress Syndrome Forecast
  10.4.2 France Market Respiratory Distress Syndrome Forecast
  10.4.3 UK Market Respiratory Distress Syndrome Forecast
  10.4.4 Italy Market Respiratory Distress Syndrome Forecast
  10.4.5 Russia Market Respiratory Distress Syndrome Forecast
10.5 Middle East & Africa Respiratory Distress Syndrome Forecast by Region (2026-2031)
  10.5.1 Egypt Market Respiratory Distress Syndrome Forecast
  10.5.2 South Africa Market Respiratory Distress Syndrome Forecast
  10.5.3 Israel Market Respiratory Distress Syndrome Forecast
  10.5.4 Turkey Market Respiratory Distress Syndrome Forecast
10.6 Global Respiratory Distress Syndrome Forecast by Type (2026-2031)
10.7 Global Respiratory Distress Syndrome Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Respiratory Distress Syndrome Forecast

11 KEY PLAYERS ANALYSIS

11.1 Chiesi Farmaceutici
  11.1.1 Chiesi Farmaceutici Company Information
  11.1.2 Chiesi Farmaceutici Respiratory Distress Syndrome Product Offered
  11.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Chiesi Farmaceutici Main Business Overview
  11.1.5 Chiesi Farmaceutici Latest Developments
11.2 CR-Double Crane
  11.2.1 CR-Double Crane Company Information
  11.2.2 CR-Double Crane Respiratory Distress Syndrome Product Offered
  11.2.3 CR-Double Crane Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 CR-Double Crane Main Business Overview
  11.2.5 CR-Double Crane Latest Developments
11.3 ONY Biotech
  11.3.1 ONY Biotech Company Information
  11.3.2 ONY Biotech Respiratory Distress Syndrome Product Offered
  11.3.3 ONY Biotech Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 ONY Biotech Main Business Overview
  11.3.5 ONY Biotech Latest Developments
11.4 AbbVie
  11.4.1 AbbVie Company Information
  11.4.2 AbbVie Respiratory Distress Syndrome Product Offered
  11.4.3 AbbVie Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 AbbVie Main Business Overview
  11.4.5 AbbVie Latest Developments
11.5 Yuhan Corporation
  11.5.1 Yuhan Corporation Company Information
  11.5.2 Yuhan Corporation Respiratory Distress Syndrome Product Offered
  11.5.3 Yuhan Corporation Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Yuhan Corporation Main Business Overview
  11.5.5 Yuhan Corporation Latest Developments
11.6 JW Pharmaceuticals
  11.6.1 JW Pharmaceuticals Company Information
  11.6.2 JW Pharmaceuticals Respiratory Distress Syndrome Product Offered
  11.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 JW Pharmaceuticals Main Business Overview
  11.6.5 JW Pharmaceuticals Latest Developments
11.7 Noargen
  11.7.1 Noargen Company Information
  11.7.2 Noargen Respiratory Distress Syndrome Product Offered
  11.7.3 Noargen Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Noargen Main Business Overview
  11.7.5 Noargen Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Respiratory Distress Syndrome Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Respiratory Distress Syndrome Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Poractant Alfa
Table 4. Major Players of Beractant
Table 5. Major Players of Calfactant
Table 6. Major Players of Others
Table 7. Respiratory Distress Syndrome Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Respiratory Distress Syndrome Market Size byType (2020-2025) & ($ millions)
Table 9. Global Respiratory Distress Syndrome Market Size Market Share byType (2020-2025)
Table 10. Respiratory Distress Syndrome Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Respiratory Distress Syndrome Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Respiratory Distress Syndrome Market Size Market Share by Application (2020-2025)
Table 13. Global Respiratory Distress Syndrome Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Respiratory Distress Syndrome Revenue Market Share by Player (2020-2025)
Table 15. Respiratory Distress Syndrome Key Players Head office and Products Offered
Table 16. Respiratory Distress Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Respiratory Distress Syndrome Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Respiratory Distress Syndrome Market Size Market Share by Region (2020-2025)
Table 21. Global Respiratory Distress Syndrome Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Respiratory Distress Syndrome Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Respiratory Distress Syndrome Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Respiratory Distress Syndrome Market Size Market Share by Country (2020-2025)
Table 25. Americas Respiratory Distress Syndrome Market Size byType (2020-2025) & ($ millions)
Table 26. Americas Respiratory Distress Syndrome Market Size Market Share byType (2020-2025)
Table 27. Americas Respiratory Distress Syndrome Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Respiratory Distress Syndrome Market Size Market Share by Application (2020-2025)
Table 29. APAC Respiratory Distress Syndrome Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Respiratory Distress Syndrome Market Size Market Share by Region (2020-2025)
Table 31. APAC Respiratory Distress Syndrome Market Size byType (2020-2025) & ($ millions)
Table 32. APAC Respiratory Distress Syndrome Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Respiratory Distress Syndrome Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Respiratory Distress Syndrome Market Size Market Share by Country (2020-2025)
Table 35. Europe Respiratory Distress Syndrome Market Size byType (2020-2025) & ($ millions)
Table 36. Europe Respiratory Distress Syndrome Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Respiratory Distress Syndrome Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Respiratory Distress Syndrome Market Size byType (2020-2025) & ($ millions)
Table 39. Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Respiratory Distress Syndrome
Table 41. Key Market Challenges & Risks of Respiratory Distress Syndrome
Table 42. Key IndustryTrends of Respiratory Distress Syndrome
Table 43. Global Respiratory Distress Syndrome Market SizeForecast by Region (2026-2031) & ($ millions)
Table 44. Global Respiratory Distress Syndrome Market Size Market ShareForecast by Region (2026-2031)
Table 45. Global Respiratory Distress Syndrome Market SizeForecast byType (2026-2031) & ($ millions)
Table 46. Global Respiratory Distress Syndrome Market SizeForecast by Application (2026-2031) & ($ millions)
Table 47. ChiesiFarmaceutici Details, CompanyType, Respiratory Distress Syndrome Area Served and Its Competitors
Table 48. ChiesiFarmaceutici Respiratory Distress Syndrome Product Offered
Table 49. ChiesiFarmaceutici Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. ChiesiFarmaceutici Main Business
Table 51. ChiesiFarmaceutici Latest Developments
Table 52. CR-Double Crane Details, CompanyType, Respiratory Distress Syndrome Area Served and Its Competitors
Table 53. CR-Double Crane Respiratory Distress Syndrome Product Offered
Table 54. CR-Double Crane Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. CR-Double Crane Main Business
Table 56. CR-Double Crane Latest Developments
Table 57. ONY Biotech Details, CompanyType, Respiratory Distress Syndrome Area Served and Its Competitors
Table 58. ONY Biotech Respiratory Distress Syndrome Product Offered
Table 59. ONY Biotech Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. ONY Biotech Main Business
Table 61. ONY Biotech Latest Developments
Table 62. AbbVie Details, CompanyType, Respiratory Distress Syndrome Area Served and Its Competitors
Table 63. AbbVie Respiratory Distress Syndrome Product Offered
Table 64. AbbVie Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. AbbVie Main Business
Table 66. AbbVie Latest Developments
Table 67. Yuhan Corporation Details, CompanyType, Respiratory Distress Syndrome Area Served and Its Competitors
Table 68. Yuhan Corporation Respiratory Distress Syndrome Product Offered
Table 69. Yuhan Corporation Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Yuhan Corporation Main Business
Table 71. Yuhan Corporation Latest Developments
Table 72. JW Pharmaceuticals Details, CompanyType, Respiratory Distress Syndrome Area Served and Its Competitors
Table 73. JW Pharmaceuticals Respiratory Distress Syndrome Product Offered
Table 74. JW Pharmaceuticals Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. JW Pharmaceuticals Main Business
Table 76. JW Pharmaceuticals Latest Developments
Table 77. Noargen Details, CompanyType, Respiratory Distress Syndrome Area Served and Its Competitors
Table 78. Noargen Respiratory Distress Syndrome Product Offered
Table 79. Noargen Respiratory Distress Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Noargen Main Business
Table 81. Noargen Latest Developments



LIST OFFIGURES

Figure 1. Respiratory Distress Syndrome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Respiratory Distress Syndrome Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Respiratory Distress Syndrome Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Respiratory Distress Syndrome Sales Market Share by Country/Region (2024)
Figure 8. Respiratory Distress Syndrome Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Respiratory Distress Syndrome Market Size Market Share byType in 2024
Figure 10. Respiratory Distress Syndrome in Very Preterm Infants
Figure 11. Global Respiratory Distress Syndrome Market: Very Preterm Infants (2020-2025) & ($ millions)
Figure 12. Respiratory Distress Syndrome in Moderate to Late Preterm Infants
Figure 13. Global Respiratory Distress Syndrome Market: Moderate to Late Preterm Infants (2020-2025) & ($ millions)
Figure 14. Respiratory Distress Syndrome in Others
Figure 15. Global Respiratory Distress Syndrome Market: Others (2020-2025) & ($ millions)
Figure 16. Global Respiratory Distress Syndrome Market Size Market Share by Application in 2024
Figure 17. Global Respiratory Distress Syndrome Revenue Market Share by Player in 2024
Figure 18. Global Respiratory Distress Syndrome Market Size Market Share by Region (2020-2025)
Figure 19. Americas Respiratory Distress Syndrome Market Size 2020-2025 ($ millions)
Figure 20. APAC Respiratory Distress Syndrome Market Size 2020-2025 ($ millions)
Figure 21. Europe Respiratory Distress Syndrome Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Respiratory Distress Syndrome Market Size 2020-2025 ($ millions)
Figure 23. Americas Respiratory Distress Syndrome Value Market Share by Country in 2024
Figure 24. United States Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Respiratory Distress Syndrome Market Size Market Share by Region in 2024
Figure 29. APAC Respiratory Distress Syndrome Market Size Market Share byType (2020-2025)
Figure 30. APAC Respiratory Distress Syndrome Market Size Market Share by Application (2020-2025)
Figure 31. China Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 35. India Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Respiratory Distress Syndrome Market Size Market Share by Country in 2024
Figure 38. Europe Respiratory Distress Syndrome Market Size Market Share byType (2020-2025)
Figure 39. Europe Respiratory Distress Syndrome Market Size Market Share by Application (2020-2025)
Figure 40. Germany Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 41.France Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Respiratory Distress Syndrome Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Respiratory Distress Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 54. APAC Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 55. Europe Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 57. United States Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 58. Canada Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 59. Mexico Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 60. Brazil Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 61. China Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 62. Japan Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 63. Korea Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 65. India Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 66. Australia Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 67. Germany Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 68.France Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 69. UK Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 70. Italy Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 71. Russia Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 72. Egypt Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 73. South Africa Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 74. Israel Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 75.Turkey Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)
Figure 76. Global Respiratory Distress Syndrome Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Respiratory Distress Syndrome Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Respiratory Distress Syndrome Market Size 2026-2031 ($ millions)